Something interesting is happening for sureWhen I checked F2G Pharma adviosry board which is another well established anti-fungal R & D company in UK, Dr. John Perfect and Prof David Denning both are mentioned as advisors.
https://www.f2g.com/advisors/
Below link is also useful to judge ICO potential.
https://www.f2g.com/antifungal-market/
I think with the phase 1 results much better than anticipated and compared to competition, something is brewing up with regard to these advisory board hirings and a possible JV might be in the pipeline. Its inevitable that they will combine forces with established anti-fungal R & D companies to fast track development of ICO-019.